NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/13/2025
Back to search
Official data from USPTO
THE ANYTIME, ANYWHERE MIGRAINE MEDICINE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
THE ANYTIME, ANYWHERE MIGRAINE MEDICINE
ST13
US500000098431829Class
35, 41, 44
Filing
98431829
Registration
7790522
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
18
Latest update
05/13/2025
Trademark type
Word
Nice classes
35, 41, 44
Filing date
03/04/2024
Registration date
05/13/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/13/2025
Last transaction
05/13/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
04/01/2020
First use in commerce
04/01/2020
Drawing code
4
Owner type
99
Owner location
COOLOCK DUBLIN, IE
Examiner
NOLASCO-ARIAS, KENNETH E
Law office
M70
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED
Representatives
Matthew O. Brady AbbVie Inc.
Technical classification
Nice Classes
Class 35Class 41Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Providing consumer product information regarding medical products to patients and healthcare professionals
Class 41
Providing non-downloadable electronic publications in the nature of information kits comprised of non-downloadable web-banners being non-downloadable graphics featuring medical and patient informationnon-downloadable web-social media content being articles in the field of treatment of neurological disorderscentral nervous system disordersheadachespainnon-downloadable web-video content being non-downloadable webcasts featuring information in the field of treatment of neurological disorderscentral nervous system disordersheadachespain; non downloadable web-website content being articles in the field of treatment of neurological disorderscentral nervous system disordersheadachespain; non-downloadable telephone-delivered content being graphics delivered to mobile phones; non-downloadable slides being non-downloadable graphicsnon-downloadable internet promotional content being articles in the field of treatment of neurological disorderscentral nervous system disordersheadachespain; non-downloadable consumer audio content being podcasts in the field of treatment of neurological disorderscentral nervous system disordersheadachespain; radio content being non-downloadable audio recordingstv spots and tv commercials being non downloadable video recordings all featuring information in the field of treatment of neurological disorderscentral nervous system disordersheadachespain; non-downloadable articles featuring web-links and URLs to websites featuring medical and patient information
Class 44
Providing medical informationinformation regarding medical conditions and treatments to patients and healthcare professionals; medical consultationproviding advice to healthcare professionals regarding medical conditions and treatment; providing medical information regarding medical products to patients and healthcare professionals
Publications
History of USPTO decisions and trademark events.
18 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/13/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/25/2025
PUBO
PUBLISHED FOR OPPOSITION
03/25/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/19/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/27/2025
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
10/29/2024
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
10/29/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/03/2024
GNRT
NON-FINAL ACTION E-MAILED
09/03/2024
CNRT
NON-FINAL ACTION WRITTEN
09/03/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
08/29/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/29/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
08/29/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/29/2024
DOCK
ASSIGNED TO EXAMINER
08/29/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/15/2024
NWAP
NEW APPLICATION ENTERED
03/04/2024
Continuous trademark protection
Get notified about every new filing that threatens THE ANYTIME, ANYWHERE MIGRAINE MEDICINE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.